Giant-cell arteritis related strokes: scoping review of mechanisms and rethinking treatment strategy?

Mickael Bonnan1, Stephane Debeugny2

  • 1Service de Neurologie, Hôpital Delafontaine, Saint-Denis, France.

Frontiers in Neurology
|December 22, 2023
PubMed

Insights

Giant cell arteritis (GCA) can cause rare but severe strokes, often due to arterial stenosis and occlusion. Understanding these mechanisms is crucial for preventing recurrent strokes and developing targeted treatments.

Area of Science:

  • Neurology
  • Rheumatology
  • Vascular Medicine

Background:

  • Stroke is a rare but severe complication of giant cell arteritis (GCA).
  • Mechanisms underlying GCA-related stroke remain incompletely understood.
  • Existing reviews have not comprehensively examined GCA-related stroke data.

Purpose of the Study:

  • To conduct a scoping review of GCA-related stroke.
  • To elucidate the mechanisms of stroke in GCA patients.
  • To identify knowledge gaps and inform future research.

Main Methods:

  • Scoping review of existing literature on GCA-related stroke.
  • Analysis of clinical presentations, imaging findings, and histopathology.
  • Discussion of potential stroke mechanisms.

Main Results:

  • GCA-related stroke may occur with normal inflammatory markers, necessitating clinical vigilance.
  • Ischemic lesions often involve stenosis or thrombosis, predominantly in the internal carotid siphon and vertebral arteries (V3-V4 segments).
  • Temporal artery biopsy reveals granulomatous inflammation and intimal hyperplasia leading to slit-like stenosis; thrombi are occasionally present.

Conclusions:

  • GCA-related stroke primarily involves hemodynamic mechanisms, including arterial stenosis and intimal hyperplasia.
  • Early diagnosis and treatment are essential, but further research into angioplasty or anti-proliferative agents may offer new therapeutic avenues.
  • Clinicians should consider GCA in stroke patients, even with normal inflammatory parameters.